Industry: Pharmaceuticals, Biotechnology
Galapagos (Euronext Brussels, GLPG; Euronext Amsterdam, GLPGA; London AiM: GLPG) is a drug discovery company with clinical and pre-clinical programs in bone and joint diseases, cachexia, and menopausal hot flashes. Its division BioFocus DPI offers a full suite of target-to-drug discovery products and services to pharmaceutical and biotech companies, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates. BioFocus DPI also provides adenoviral reagents for rapid identification and validation of novel drug targets, compound libraries for drug screening as well as chemogenomics and ADMET database products to select targets and ( www.galapagosgenomics.com )
Galapagos NV
Chesterford Research Park
Saffron Walden, Essex CB10 1XL
United Kingdom
Tel: +44 1799 533500
Fax: +44 1799 531495